Suli Co Ltd Class A

Suli Co Ltd Class A

SSSE:603585
8.91
CNY
-0.04
(-0.45%)
0.43EPS
25.41P/E
2.90BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
4.45
4.72
5.92
6.94
5.79
6.52
7.17
6.18
9.31
12.49
7.66
9.12
10.91
10.51
Basic EPS, GAAP
0.33
0.37
0.62
0.95
0.89
1.24
1.2
0.69
0.96
1.25
0.08
-0.04
0.76
0.41
Free Cash Flow per Basic Share
0.44
0.46
0.41
0.67
0.8
1.11
0.41
-0.18
-0.01
-0.33
-1.74
-2.93
-0.44
- -
Dividend per Share
0.16
0.04
0.02
0.01
0.28
0.3
0.43
0.43
0.21
0.26
0.44
0.22
0.09
0.37
Book Value per Share
1.77
2.17
2.82
5.34
6.02
6.99
7.78
8.05
8.76
10.38
9.84
9.58
10.34
10.46
Tangible Book Value per Share
1.59
1.98
2.63
5.2
5.89
6.7
7.49
7.52
8.24
9.88
9.08
8.85
9.64
9.8
Basic Weighted Avg Shares
183
188
190
195
252
253
253
252
252
252
256
253
255
262
Sales/Revenue/Turnover
813
890
1,123
1,351
1,457
1,646
1,813
1,559
2,348
3,150
1,958
2,309
2,777
2,749
Operating Margin (%)
14.67
12.27
16.37
20.73
25.59
28.98
25.2
15.62
14.62
13.72
2.18
1.2
11.47
8.32
Depreciation Expense
27
34
36
40
43
48
52
79
103
120
130
226
310
- -
Net Income, GAAP
59
69
118
185
225
312
303
175
241
315
20
-11
193
108
Effective Tax Rate (%)
16.33
16.26
15.4
15.78
16.77
16.02
15.87
15.26
13.74
14.54
29.35
- -
15.56
12.78
Profit Margin (%)
7.31
7.73
10.52
13.72
15.42
18.96
16.73
11.21
10.28
10.01
1.03
-0.47
6.94
3.94
Working Capital
164
174
307
1,153
1,342
1,613
1,535
1,281
1,249
2,123
1,182
928
1,143
1,317
LT Debt
45
- -
- -
- -
- -
- -
- -
7
4
867
1,075
1,234
1,270
1,229
Total Equity
465
568
730
1,635
1,882
2,237
2,537
2,520
2,704
3,342
3,207
3,190
3,427
3,626
Return on Invested Capital (%)
14.21
14.12
22.17
21.2
17.24
20.54
17.02
8.7
11.16
11.15
0.39
- -
4.46
- -
Return on Capital (%)
7.76
7.72
11.08
9.45
7.98
9.15
8.31
5.15
7.19
7.45
1.07
- -
4.86
- -
Return on Common Equity (%)
21.26
18.5
25.07
19.74
15.7
19.05
16.3
8.76
11.4
13.07
0.79
-0.44
7.46
- -

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
80
99
110
LT Borrowings
1,256
1,232
1,225
LT Finance Leases
5
4
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
262
275
275
Market Capitalization
4,149
2,689
2,899

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,984
2,205
2,123
Cash, Cash Equivalents & STI
531
653
559
Accounts Receivable, Net
541
575
568
Inventories
586
675
660
Total Current Liabilities
785
896
806
Payables & Accruals
- -
- -
- -
ST Debt
80
99
110
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
20.45%
6.75%
7.45%
Free Cash Flow
331.89%
673.1%
-84.78%
Net Income, GAAP
-198.38%
-411.12%
-1,876.71%
Sales/Revenue/Turnover
12.24%
17.03%
20.28%
Total Cash Common Dividend
515.48%
-13.98%
-60.52%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
485
556
605
663
2,309
2025
647
655
- -
713
2,777
2026
608
727
701
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
0.04
0.01
-0.08
-0.04
2025
0.14
0.18
- -
0.21
0.76
2026
0.09
0.12
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.06
0.03
0.11
0.22
2025
0.05
0.01
- -
0.01
0.09
2026
0.14
-0.06
0.27
- -
- -

Company Description

CEO
Jing Li Wang
Full Time Employees
1,898
Sector
Process industries
Industry
Chemicals: agricultural
Address
No.7-1, Runhua Road Jiangyin JS China 214444
IPO Date
Dec 14, 2016
Website
suli.com
Business
Suli Co., Ltd. Suli Co., Ltd. (603585.SS) engages in the research, development, production, and sale of pesticides, flame retardants, and other fine chemicals. The company manufactures chlorothalonil technical, azoxystrobin technical, diflubenzuron, fluazinam, cymoxanil, boscalid technical, and other pesticide products including formulations and agents; flame retardants such as decabromodiphenylethane, flame retardant masterbatch, brominated polystyrene, and melamine pyrophosphate; and additional fine chemicals comprising hydrobromic acid, pharmaceutical intermediates, industry biocides like Longee 985CHL, 550CCD, 550CC, and 500CHL, and ferric chloride solution for water treatment. Suli Co., Ltd. sells its products, marketed under the Suli brand, primarily to agricultural production, plastics, building materials, and pharmaceutical sectors; it operates with a workforce of 1,825 employees and generates significant revenue from pesticide-type products (approximately 1.29 billion CNY in 2024), retardant-type products (721 million CNY), and other fine chemicals (250 million CNY). Geographically, the company maintains a strong domestic presence in China while exporting to the European Union, North America, South America, Africa, Southeast Asia, and other regions. Founded prior to its 2012 listing on the Shanghai Stock Exchange and headquartered at 7-1 Runhua Road, Lingang Street, Jiangyin, Jiangsu Province, China, Suli Co., Ltd. continues to innovate through its experienced R&D team and advanced laboratories. Recently, the company provided funding to Suli New Material Technology Co., Ltd., including CNY 123.5 million from Suli Co., Ltd., Oxon Asia srl, and Sipcam Asia S.R.L., as well as an additional CNY 270 million alongside Oxon Asia srl, supporting advancements in new materials and fine chemical technologies; it also announced a financing transaction in April 2025 and reported first-quarter earnings for the period ended March 31, 2025.